Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -39.63% is 35% above its 4-year average of -60.94%, near the high end of its 4-year range (-134.54%–-39.63%).
As of the fiscal period ended Tuesday, June 30, 2026. 12.33% above its 12-month average of -45.20%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -39.63%.
RETURN ON INVESTED CAPITAL (ROIC)
-39.63%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-45.20%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-56.24%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+12.33%
CURRENT VS 3Y AVG
+29.54%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-11.18%
vs the sector median at left
Oculis Holding AG
Market Cap
$498.52M
Return on Invested Capital (ROIC)
-39.63%
TTM Avg
-45.20%
3Y Avg
-56.24%
5Y Avg
N/A
Market Cap
$499.40M
Return on Invested Capital (ROIC)
9.54%
TTM Avg
6.91%
3Y Avg
3.66%
5Y Avg
1.89%
Market Cap
$502.81M
Return on Invested Capital (ROIC)
-43.41%
TTM Avg
-39.91%
3Y Avg
-39.91%
5Y Avg
-39.91%
Market Cap
$503.93M
Return on Invested Capital (ROIC)
-34.79%
TTM Avg
-53.61%
3Y Avg
-51.25%
5Y Avg
-40.96%
Market Cap
$504.04M
Return on Invested Capital (ROIC)
-102.59%
TTM Avg
-133.31%
3Y Avg
-119.78%
5Y Avg
-99.25%
Market Cap
$505.87M
Return on Invested Capital (ROIC)
-18.90%
TTM Avg
-35.16%
3Y Avg
-27.40%
5Y Avg
-20.34%
Market Cap
$486.01M
Return on Invested Capital (ROIC)
-15.54%
TTM Avg
-22.63%
3Y Avg
-32.48%
5Y Avg
-46.23%
Market Cap
$483.54M
Return on Invested Capital (ROIC)
18.26%
TTM Avg
19.81%
3Y Avg
16.87%
5Y Avg
7.92%
Market Cap
$516.76M
Return on Invested Capital (ROIC)
-56.99%
TTM Avg
-66.45%
3Y Avg
-57.50%
5Y Avg
-60.06%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Oculis Holding AG (OCS) | $498.52M | -39.63% | -45.20% | -56.24% | N/A |
| Tactile Systems Technology, Inc. (TCMD)vs › | $499.40M | 9.54% | 6.91% | 3.66% | 1.89% |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $502.81M | -43.41% | -39.91% | -39.91% | -39.91% |
| Allogene Therapeutics, Inc. (ALLO)vs › | $503.93M | -34.79% | -53.61% | -51.25% | -40.96% |
| Crescent Biopharma, Inc. (CBIO)vs › | $504.04M | -102.59% | -133.31% | -119.78% | -99.25% |
| 908 Devices Inc. (MASS)vs › | $505.87M | -18.90% | -35.16% | -27.40% | -20.34% |
| Evolus, Inc. (EOLS)vs › | $486.01M | -15.54% | -22.63% | -32.48% | -46.23% |
| Puma Biotechnology, Inc. (PBYI)vs › | $483.54M | 18.26% | 19.81% | 16.87% | 7.92% |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $516.76M | -56.99% | -66.45% | -57.50% | -60.06% |
| Altimmune, Inc. (ALT)vs › | $519.25M | -19.47% | -57.88% | -52.57% | -47.02% |
ROIC
-39.6%
ROE
-36.8%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -39.63% |
| 2026-03-31 | -42.39% |
| 2025-12-31 | -39.87% |
| 2025-09-30 | -55.37% |
| 2025-06-30 | -48.75% |
| 2025-03-31 | -47.32% |
| 2024-12-31 | -98.42% |
| 2024-09-30 | -67.48% |
| 2024-06-30 | -55.05% |
| 2024-03-31 | -64.52% |
| 2023-12-31 | -79.18% |
| 2023-09-30 | -74.70% |
| 2023-06-30 | -60.64% |
| 2022-12-31 | -134.54% |
| 2022-09-30 | -80.47% |
| 2022-06-30 | -60.29% |
